Literature DB >> 2517321

Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance.

J M Pochet1, G Bobrie, P Landais, B Goldfarb, J P Grünfeld.   

Abstract

Progressive hereditary nephritis is subdivided into Alport's syndrome (with extrarenal involvement) and hereditary nephritis without deafness. Three modes of inheritance have been described: X-linked dominant, autosomal dominant, and autosomal recessive. We reviewed the mode of inheritance in 48 kindred with hereditary nephritis (41 with Alport's syndrome and 7 with hereditary nephritis without deafness). It was presumed X-linked dominant in 34 Alport's syndrome and 6 hereditary nephritis without deafness, autosomal dominant in five hereditary nephritis and one hereditary nephritis without deafness, and autosomal recessive in two Alport's syndrome. We studied the cumulative renal survival of 149 patients, 128 (76 males, 52 females) with Alport's syndrome and 21 (10 males, and 11 females) with hereditary nephritis without deafness. Major prognostic factors were the patient's sex (median renal survival in males and females being respectively 32 versus 61 years in Alport's syndrome and 34 versus 57 years in hereditary nephritis without deafness), and the mode of inheritance (median renal survival in males being 25 years in X-linked dominant Alport's syndrome versus 51 years in autosomal dominant Alport's syndrome). The presence of hearing loss in the kindred or in the patient himself did not appear as a significant prognostic factor. We conclude that Alport's syndrome and hereditary nephritis without deafness are predominantly X-linked dominant diseases with the same renal outcome, and that in Alport's syndrome the patient's sex and the mode of inheritance are two independent prognostic factors.

Entities:  

Mesh:

Year:  1989        PMID: 2517321

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments.

Authors:  B Knebelmann; G Deschenes; F Gros; M C Hors; J P Grünfeld; J Zhou; K Tryggvason; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

Review 2.  Molecular aspects of Alport's syndrome.

Authors:  M Weber; K O Netzer; O Pullig
Journal:  Clin Investig       Date:  1992-09

Review 3.  Population-based studies reveal an additive role of type IV collagen variants in hematuria and albuminuria.

Authors:  Moumita Barua; Andrew D Paterson
Journal:  Pediatr Nephrol       Date:  2021-02-26       Impact factor: 3.714

4.  Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients.

Authors:  Sawssan Ammar; Houda Kanoun; Khawla Kammoun; Andrea Domingo-Gallego; Patricia Ruiz; Laura Lorente-Grandoso; Marc Pybus; Bayen Maalej; Tahya Boudawara; Hassen Kamoun; Mohamed Ben Hmida; Elisabet Ars; Faiçal Jarraya
Journal:  J Hum Genet       Date:  2021-03-02       Impact factor: 3.172

5.  Identification of a novel collagen type IV alpha-4 (COL4A4) mutation in a Chinese family with autosomal dominant Alport syndrome using exome sequencing.

Authors:  Sheng Deng; Hongbo Xu; Jinzhong Yuan; Jingjing Xiao; Lamei Yuan; Xiong Deng; Liping Guan; Anding Zhu; Pengfei Rong; Jianguo Zhang; Hao Deng
Journal:  Indian J Med Res       Date:  2016-08       Impact factor: 2.375

6.  Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene.

Authors:  C Cervera-Acedo; A Coloma; E Huarte-Loza; M Sierra-Carpio; E Domínguez-Garrido
Journal:  BMC Nephrol       Date:  2017-10-31       Impact factor: 2.388

7.  Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.

Authors:  Jian-Hong Liu; Xiu-Xiu Wei; Ang Li; Ying-Xia Cui; Xin-Yi Xia; Wei-Song Qin; Ming-Chao Zhang; Er-Zhi Gao; Jun Sun; Chun-Lin Gao; Feng-Xia Liu; Qiu-Yue Wu; Wei-Wei Li; Zhi-Hong Liu; Xiao-Jun Li
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

Review 8.  Renal transplantation in patients with Alport syndrome: patient selection, outcomes, and donor evaluation.

Authors:  Clifford E Kashtan
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-10-16

9.  Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome.

Authors:  Shunlai Shang; Fei Peng; Tao Wang; Xiaoyuan Wu; Ping Li; Qinggang Li; Xiang M Chen
Journal:  Mol Genet Genomic Med       Date:  2019-05-29       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.